Document is current
Any future updates will be listed below
-
Authors
Cesana, Marcella https://orcid.org/0000-0002-9099-8681
Tufano, Gennaro
Panariello, Francesco
Zampelli, Nicolina
Soldati, Chiara
Mutarelli, Margherita
Montefusco, Sandro
Grieco, Giuseppina
Sepe, Lucia Vittoria
Rossi, Barbara
Nusco, Edoardo
Rossignoli, Giada
Panebianco, Giorgia
Merciai, Fabrizio
Salviati, Emanuela
Sommella, Eduardo Maria https://orcid.org/0000-0001-8654-6431
Campiglia, Pietro
Martello, Graziano https://orcid.org/0000-0001-5520-085X
Cacchiarelli, Davide
Medina, Diego Luis https://orcid.org/0000-0002-7347-2645
Ballabio, Andrea https://orcid.org/0000-0003-1381-4604
- License Information
-
More Information
Article History
Received: 27 May 2024
Revised: 17 June 2024
Accepted: 25 June 2024
First Online: 4 July 2024
Competing interests
: AB is cofounder and shareholder of Casma Therapeutics and an advisory board member of Avilar Therapeutics. DC is Co-Founder, shareholder and Consultant of NEGEDIA Srl.
: The study does not involve human subjects, human material, or human data that requires ethical approval. Human data and samples utilized in the study derived from publicly available unrestricted databases and commercial cell lines.
